NSMRX
Price
$41.32
Change
+$0.09 (+0.22%)
Updated
Jul 31 closing price
Net Assets
130.14M
VSCPX
Price
$408.08
Change
-$0.97 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

NSMRX vs VSCPX

NSMRX vs VSCPX Comparison Chart in %
View a ticker or compare two or three
VS
NSMRX vs. VSCPX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSMRX is a Buy and VSCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 189B vs. NSMRX (130M). VSCPX pays higher dividends than NSMRX: VSCPX (1.24) vs NSMRX (0.58). NSMRX was incepted earlier than VSCPX: NSMRX (20 years) vs VSCPX (16 years). NSMRX (1.10) is less costly to investors than VSCPX (0.02). NSMRX is a more actively managed with annual turnover of: 64.00 vs. VSCPX (17.00). NSMRX has a lower initial minimum investment than VSCPX: NSMRX (100000) vs VSCPX (100000000). NSMRX annual gain was more profitable for investors over the last year : 24.79 vs. VSCPX (22.59). VSCPX return over 5 years is better than : 35.15 vs. NSMRX (31.05).
NSMRXVSCPXNSMRX / VSCPX
Total Expense Ratio0.910.024,550%
Annual Report Gross Expense Ratio1.100.025,500%
Fund Existence20 years16 years-
Gain YTD19.00914.596130%
Front LoadN/AN/A-
Min. Initial Investment1000001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets130M189B0%
Annual Yield % from dividends0.581.2447%
Returns for 1 year24.7922.59110%
Returns for 3 years43.6043.45100%
Returns for 5 years31.0535.1588%
Returns for 10 years46.40156.1230%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSVUX19.650.22
+1.13%
Goldman Sachs Large Cap Value R6
FDTCX36.220.31
+0.86%
Fidelity Advisor Diversified Stock C
MGTCX7.200.03
+0.42%
Transamerica Mid Cap Growth C
CSPCX66.050.22
+0.33%
American Funds SMALLCAP World 529-C
CCVAX30.170.07
+0.23%
Calvert Small-Cap A